Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F13A1 | P00488 | 8/20 | 0.51 |
| ▸ | TGM2 | P21980 | 8/20 | 0.51 |
| ▸ | TGM1 | P22735 | 8/20 | 0.51 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.51 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.46 |
| ▸ | TGM6 | O95932 | 1/20 | 0.46 |
| ▸ | RORC | P51449 | 2/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30690890 | 1.00 | F13A1 (0.51) | F13A1TGM2TGM1TGM3GPR119 | |
| SCHEMBL30810384 | 0.94 | GPR119 (0.53) | F13A1TGM2TGM1TGM3GPR119 | |
| SCHEMBL27298866 | 0.93 | DRD2 (0.49) | F13A1TGM2TGM1TGM3GPR119 | |
| SCHEMBL29640956 | 0.93 | DRD2 (0.49) | F13A1TGM2TGM1TGM3GPR119 | |
| SCHEMBL24571712 | 0.92 | TMEM97 (0.45) | F13A1TGM2TGM1TGM3GPR119 | |
| SCHEMBL29640929 | 0.86 | TGM2 (0.49) | F13A1TGM2TGM1TGM3PKM | |
| SCHEMBL24571938 | 0.86 | TGM2 (0.49) | F13A1TGM2TGM1TGM3PKM | |
| SCHEMBL29640961 | 0.83 | F13A1 (0.45) | F13A1TGM2TGM1TGM3PKM | |
| SCHEMBL27298520 | 0.83 | F13A1 (0.45) | F13A1TGM2TGM1TGM3PKM | |
| SCHEMBL30690894 | 0.82 | F13A1 (0.45) | F13A1TGM2TGM1TGM3PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116783205-A | Compounds for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway | 尼坎治疗公司 | 2023-09-19 | — | — | CN | disclosed |